News

from the fight to #SaveIndiePharmacy

New York Times’ The Middlemen series

“Slow Pay, Low Pay or No Pay”
ProPublica St. Paul Corner Drug (SPCD) ProPublica St. Paul Corner Drug (SPCD)

“Slow Pay, Low Pay or No Pay”

Blue Cross Louisiana OK’d mastectomies and breast reconstructions for women with cancer but refused to pay a hospital’s full bills. For some claims, it paid nothing. This investigation has led to actors and advocates to bring stories like this one to life, which can be viewed here

Read More
PBM Prime Therapeutics to Pay $10 Million Antitrust Case Over Price-Fixing Scheme with Express Scripts, Inc.
Policy & Medicine St. Paul Corner Drug (SPCD) Policy & Medicine St. Paul Corner Drug (SPCD)

PBM Prime Therapeutics to Pay $10 Million Antitrust Case Over Price-Fixing Scheme with Express Scripts, Inc.

In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and Blue Shield Plans, was found guilty of engaging in horizontal price-fixing in collaboration with Express Scripts, Inc. (ESI), a competitor owned by Cigna.

Read More
UnitedHealth Group ordered to pay $165 million over deceptive sales practices
The Minnesota Star Tribune St. Paul Corner Drug (SPCD) The Minnesota Star Tribune St. Paul Corner Drug (SPCD)

UnitedHealth Group ordered to pay $165 million over deceptive sales practices

UnitedHealth Group will appeal an order to pay $165 million in penalties and restitution after a judge found a business acquired by the Eden Prairie-based insurer more than five years ago used deceptive practices to sell benefits that supplement traditional health insurance in Massachusetts.

Read More